Researchers recently compared the effects of treatment with an atypical antipsychotic vs placebo for various periods of time among patients with Alzheimer disease psychosis.
Researchers set out to determine whether attention-deficit/hyperactivity disorder predisposes individuals to the development of neuropsychiatric symptoms. The researchers presented their findings at the...
Researchers sought to determine the efficacy of brexpiprazole in reducing agitation symptoms in patients with dementia due to Alzheimer disease. The results were presented at the Alzheimer Association...
